(Q33386923)

26 July 2017

6th International Immunoglobulin Symposium: poster presentations (English)

1 reference

26 July 2017

J Bayry

11

0 references

Anne Durandy

object named as

A Durandy

4

0 references

James Bruce Bussel

8

object named as

J B Bussel

1 reference

26 July 2017

E Fernandez-Cruz

1

1 reference

26 July 2017

S V Kaveri

2

1 reference

26 July 2017

H-H Peter

3

1 reference

26 July 2017

N Cantoni

5

1 reference

26 July 2017

I Quinti

6

1 reference

26 July 2017

R Sorensen

7

1 reference

26 July 2017

M G Danieli

9

1 reference

26 July 2017

A Winkelmann

10

1 reference

26 July 2017

F Käsermann

12

1 reference

26 July 2017

P Späth

13

1 reference

26 July 2017

M Helbert

14

1 reference

26 July 2017

A Salama

15

1 reference

26 July 2017

I N van Schaik

16

1 reference

26 July 2017

N Yuki

17

1 reference

26 July 2017

1 December 2009

1 reference

Clinical and Experimental Immunology

26 July 2017

1 reference

26 July 2017

158 Suppl 1

1 reference

26 July 2017

60-67

1 reference

Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia

26 July 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2009.04028.X

DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Diagnosis and management of neonatal alloimmune thrombocytopenia

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Intravenous immunoglobulin: adverse reactions and management

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Safety of IGIV therapy and infusion-related adverse events

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Alloimmune thrombocytopenia: state of the art 2006.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Endonucleolytic function of MutLalpha in human mismatch repair.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Use of intravenous immunoglobulin G (IVIG).

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Adverse effects of intravenous immunoglobulin therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2801033

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19883425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Intravenous administration of human gamma-globulin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19883425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Intravenous immunoglobulin treatment in autoimmune diseases]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19883425

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2249.2009.04028.X

1 reference

26 July 2017

0 references

1 reference